Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung

Explore clinical trials studying Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung trial results

Recruiting

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT07489066

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations
  • Hope and Healing Clinical Research Hinsdale, Illinois, United States
  • Hope and Healing Clinical Research New Lenox, Illinois, United States
  • Pan American Center for Oncology Trials, LLC - Manati Office Manati, Puerto Rico
  • Clearview Cancer Institute (Crestwood) Huntsville, Alabama, United States
View all 14 locations
View Trial Details
Recruiting

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

NCT07519655

Conditions
Cutaneous Melanoma, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Presbyterian/St Lukes Medical Center Denver, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute- Pharmacy Nashville, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

NCT03456063

Conditions
Non-Small-Cell Lung
Locations
  • Arizona Oncology Tucson, Arizona, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • The Center for Cancer Prevention and Treatment at St.Joseph Hospital of Orange Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
View all 122 locations
View Trial Details
Completed

Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer

NCT04362072

Conditions
Carcinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
Locations
  • UCI Medical Center/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Rajiv Gandhi Cancer Institute And Research Centre New Delhi, DEL, India
  • Healthcare Global Enterprises Bengaluru, Karnataka, India
  • Bhakti Vedanta Hospital and Research Institute Thane, Maharashtra, India
View all 31 locations
View Trial Details
Completed

A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).

NCT00863746

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Fayetteville, Arkansas, United States
  • Stanford, California, United States
  • Philadelphia, Pennsylvania, United States
  • Ramos Mejía, Buenos Aires, Argentina
View all 182 locations
View Trial Details
Completed

Iressa Expanded Access Program (EAP)

NCT00034879

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Anniston, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Gadsen, Alabama, United States
View all 626 locations
View Trial Details
Active, Not Recruiting

Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

NCT05261399

Conditions
Carcinoma, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Honolulu, Hawaii, United States
  • Research Site New Brunswick, New Jersey, United States
  • Research Site New York, United States
View all 226 locations
View Trial Details

Related conditions